Stocks-BRKR-Bruker Corp

BRKR Bruker Corp

67.85 -0.40 (-0.59%)
Market OpenDelayed Prices By NASDAQ, in USD
Trade

Overview

Prev Close 68.26
Day's Range 65.67 - 68.11
52 Week Range 53.70 - 94.63
Average Volume (3M) 1.03M
1-Year Return 6.10%
Beta1.0814
Market Cap 10.33B
P/E Ratio28.37
Revenue3.12B
EPS2.4058
Dividend (Yield) 0.2 (0.29%)
Industry
Medical Specialties
CEO
Frank H. Laukien, PhD
Employees
9,707

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2023: Bruker Corp's revenues increased by 17.14% and amounted to 2.96B. Net income increased by 43.55% to 428.50M. Net assets increased by 24.87% to 1.41B and EPS increased from 1.99 to 2.90.
BRKR's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Created with Highcharts 4.2.7 /Highstock 4.2.7Total RevenueNet Income09/2312/2303/2406/240200M400M600M800M1 000M
Gross Margin
50.08%
Net Profit Margin
11.01%
Operating Margin
13.44%
Return On Investment
12.11%
09/23
12/23
03/24
06/24
Total Revenue
742.8M
854.5M
721.7M
800.7M
Gross Profit
382.8M
428.3M
351.2M
385.1M
Operating Income
130.9M
107.6M
71.5M
61.7M
Net Income
88.7M
204.6M
52M
7.6M